AnovaOS Network Powered Patient Registry
The objective of this study is the development, implementation and management of a registry of patient data that captures clinically meaningful, real-world, data on the diagnosis, nature, course of infection, treatment(s) and outcomes in patients with complex disease globally.
Conditions:
🦠 Infectious Disease 🦠 Neoplasms 🦠 Diseases of the Blood and Blood-Forming Organs and Certain Disorders Involving the Immune Mechanism (D50-D89) 🦠 Endocrine, Nutritional and Metabolic Diseases (E00-E89) 🦠 Mental and Behavioural Disorders 🦠 Diseases of the Nervous System 🦠 Diseases of the Eye and Adnexa 🦠 Diseases of the Ear and Mastoid Process 🦠 Diseases of the Circulatory System 🦠 Diseases of the Respiratory System 🦠 Diseases of the Digestive System 🦠 Diseases of the Skin and Subcutaneous Tissue 🦠 Diseases of the Musculoskeletal System and Connective Tissue 🦠 Diseases of the Genitourinary System 🦠 Pregnancy, Childbirth and the Puerperium 🦠 Certain Conditions Originating in the Perinatal Period 🦠 Congenital Malformations, Deformations and Chromosomal Abnormalities (Q00-Q99) 🦠 Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified 🦠 Injury, Poisoning and Certain Other Consequences of External Causes 🦠 External Causes of Morbidity and Mortality 🦠 Factors Influencing Health Status and Contact With Health Services
🗓️ Study Start (Actual) 1 September 2021
🗓️ Primary Completion (Estimated) 31 August 2025
✅ Study Completion (Estimated) 31 August 2026
👥 Enrollment (Estimated) 100000
🔬 Study Type OBSERVATIONAL
📊 Phase N/A
Locations:
📍 Arlington Heights, Illinois, United States

📋 Eligibility Criteria

Description

    Inclusion Criteria:

    • * 18 years old or older;
    • * Confirmed positive diagnosis of disease, condition or disorder. This will be self-reported or reported by the patient's provider, advocacy group or other patient representative;
    • * Laboratory or other independent means of confirmation is not required but may be confirmed in clinical trials;
    • * Able to understand and willing to sign the informed consent document; or whose legal representative has given consent to participate in the research per state and Federal requirements;
    • * Willing and able to complete the registry questions or have the instrument(s) completed by an informed proxy;
    • * Anticipated additional follow up with the registry once per year.

    Exclusion Criteria:

    • * Subjects who do not meet the inclusion criteria for the study;
    • * Subjects who are unable to understand the protocol or unable to provide legally effective informed consent
Ages Eligible for Study: 18 Years to N/A (ADULT, OLDER_ADULT)
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: Yes

🗓️ Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

  • First Submitted 18 August 2021
  • First Submitted that Met QC Criteria 18 August 2021
  • First Posted 20 August 2021

Study Record Updates

  • Last Update Submitted that Met QC Criteria 29 January 2024
  • Last Update Posted 30 January 2024
  • Last Verified January 2024